Draupnir Bio
PrivateLast Round
Seed
Jul 17, 2024
Total Funding Raised
$48.91M
Company Overview
Draupnir Bio is a biotechnology company that develops oral, small molecule degraders of extracellular disease-causing proteins by harnessing the natural machinery of the lysosome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Draupnir Bio Comparables
Compare Draupnir Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avilar Therapeutics | 82% | |
| Lycia Therapeutics | 79% | |
| Cullgen | 76% | |
Draupnir Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 17, 2024 | ||||
| Series A | Oct 1, 2019 | ||||
| Grant | Nov 30, 2017 | ||||
| Seed | Apr 1, 2017 |
Key People
Founding team and executive leadership
Draupnir Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Novo Nordisk Foundation | Grant |
| MP Healthcare Venture Management | Seed |
| Gilde Healthcare | Seed, Series A |
| Novo Holdings | Seed |
| The Export and Investment Fund of Denmark | Seed |
| Inkef Capital | Seed, Series A |
| High-Tech Gründerfonds | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 17, 2024
$13.1M round led by MP Healthcare and The Export and Investment Fund of Denmark.
- Oct 1, 2019
$33M round led by Gilde Healthcare, High-Tech Gründerfonds, Inkef Capital, and novoholdings.
Draupnir Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Draupnir Bio's valuation, stock price, and market status.